USPTO Examiner MENDEZ MANUEL A - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19229627AI-Ready Stationary IV Pole System for Real-Time Medical Device Integration, Role-Based Alert Rendering, and Governance-Compliant Clinical CommunicationJune 2025September 2025Allow300NoNo
19177537Adaptive Neuro-Fuzzy Inference System for closed loop Total Intravenous Anesthesia ManagementApril 2025October 2025Allow601NoNo
19054756URINE OUTPUT SENSING WITHOUT USE OF AN INDWELLING CATHETER, AND ASSOCIATED SYSTEMS, DEVICES, AND METHODSFebruary 2025November 2025Allow910YesNo
19040893SYSTEM AND METHOD FOR ADMINISTRATION OF A SUBSTANCEJanuary 2025August 2025Allow710YesNo
19028890DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISMJanuary 2025March 2025Allow200NoNo
19013766MEDIAL BRANCH SMART TIP NEEDLEJanuary 2025October 2025Allow911YesNo
19007650AUTOPILOT DRUG-DELIVERY SYSTEMJanuary 2025August 2025Allow811YesNo
19000461Smart IV Pole: An Integrated Solution for Medical Device Connectivity, Patient Monitoring, and CommunicationDecember 2024May 2025Allow410YesNo
18968283DOSING OF INCRETIN PATHWAY DRUGSDecember 2024May 2025Allow510NoNo
18960071Medicament Container Carrier and AdapterNovember 2024February 2025Allow300NoNo
18960800Medicament Container Carrier and AdapterNovember 2024August 2025Allow911NoNo
18960470Medicament Container Carrier and AdapterNovember 2024June 2025Allow601NoNo
18957952Medicament Container Carrier and AdapterNovember 2024June 2025Allow601NoNo
18918018METHOD OF PROVIDING A PERSONAL DRUG INJECTION SYSTEMOctober 2024September 2025Allow1111YesNo
18897207Using Staggered Changes in Amplitude and Frequency to Ameliorate Electrosensation During Treatment with Alternating Electric FieldsSeptember 2024October 2025Allow1310NoNo
18806797INTEGRATED INSULIN DELIVERY SYSTEM WITH CONTINUOUS GLUCOSE SENSORAugust 2024April 2025Allow811YesNo
18785610INTEGRATED INSULIN DELIVERY SYSTEM WITH CONTINUOUS GLUCOSE SENSORJuly 2024September 2024Allow200NoNo
18735124METHOD AND SYSTEM FOR TUNING HORMONE RECEPTORS THROUGH THE DYNAMIC INTRAVENOUS DELIVERY OF A HORMONE ACCORDING TO A TARGET PHYSIOLOGICAL CADENCEJune 2024October 2024Allow510YesNo
18599791Medicament Container Carrier and AdapterMarch 2024May 2024Allow300NoNo
18428921BLOOD GLUCOSE SENSING SYSTEMJanuary 2024August 2024Allow710YesNo
18426297LIQUID MEDICINE INJECTION DEVICEJanuary 2024May 2024Allow300NoNo
18407094COMBINED NEEDLE AND CANNULAJanuary 2024October 2024Abandon910NoNo
18390338AUTOMATICALLY OR MANUALLY INITIATED MEAL BOLUS DELIVERY WITH SUBSEQUENT AUTOMATIC SAFETY CONSTRAINT RELAXATIONDecember 2023May 2024Allow510NoNo
18538438IMPLANTABLE CELLULAR AND BIOTHERAPEUTIC AGENT DELIVERY CANISTERDecember 2023December 2024Allow1220NoNo
18482596INSULIN MANAGEMENTOctober 2023February 2024Allow410YesNo
18373558SYSTEMS AND METHODS FOR COACHING INHALER USE VIA SYNCHRONIZING PATIENT AND RESPIRATORY CYCLE BEHAVIORSSeptember 2023December 2023Allow300NoNo
18235091BIOINTEGRATIVE IMPLANTABLE CELL ENCAPSULATION DEVICE AND SYSTEMAugust 2023May 2024Allow900NoNo
18205365PRE-CONNECTED ANALYTE SENSORSJune 2023November 2025Allow2920YesNo
18325564METHOD, SYSTEM AND COMPUTER PROGRAM PRODUCT FOR CGM-BASED PREVENTION OF HYPOGLYCEMIA VIA HYPOGLYCEMIA RISK ASSESSMENT AND SMOOTH REDUCTION INSULIN DELIVERYMay 2023January 2024Allow820NoNo
18316863FLUID DELIVERY ADJUSTMENTS BASED ON PREDICTED PHYSIOLOGICAL CONDITIONSMay 2023August 2025Allow2820YesNo
18316703TECHNIQUES TO REDUCE RISK OF OCCLUSIONS IN DRUG DELIVERY SYSTEMSMay 2023March 2025Allow2200NoNo
18314791REAL-TIME MEAL DETECTION BASED ON SENSOR GLUCOSE AND ESTIMATED PLASMA INSULIN LEVELSMay 2023July 2023Allow200NoNo
18310731APPARATUS AND METHOD FOR SENSOR DEPLOYMENT AND FIXATIONMay 2023June 2025Allow2510NoNo
18033137METHOD FOR CONTROLLING ARTIFICIAL PANCREAS INCLUDING INSULIN PATCH AND DEVICE THEREFORApril 2023November 2023Allow700NoNo
18304117INFUSION PUMP SYSTEM AND METHODSApril 2023October 2023Allow610NoNo
18295015Insulin ManagementApril 2023June 2023Allow300NoNo
18190678ACTIVITY MODE FOR ARTIFICIAL PANCREAS SYSTEMMarch 2023June 2025Allow2710NoNo
18122012Acoustic Method for Precisely Controlling and Metering the Manual Injection DosageMarch 2023November 2023Allow810NoNo
18183051SUBSTANCE DELIVERY DEVICEMarch 2023January 2026Abandon3410NoNo
18119650IV FLOW MANAGEMENT SYSTEMS AND METHODSMarch 2023May 2025Allow2710NoNo
18116962LIQUID MEDICINE INJECTION DEVICEMarch 2023October 2023Allow800NoNo
18024278UNILATERALLY DRIVEN DRUG INFUSION DEVICEMarch 2023March 2026Allow3610NoNo
18176532SYSTEMS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTSMarch 2023May 2024Allow1410NoNo
18114961ASSEMBLIES, SYSTEMS AND METHODS FOR PROGRAMMING MEDICAL DEVICESFebruary 2023May 2024Allow1510YesNo
18111102EXTERNAL SIGNALING SAFEGUARDS FOR INFUSION PUMPFebruary 2023October 2025Allow3200NoNo
18169875Method and System of A Remote Control Respiratory TherapyFebruary 2023March 2026Allow3710NoNo
18108195MULTIPLE USE DISPOSABLE INJECTION PENFebruary 2023February 2025Allow2400NoNo
18107074METHOD, DEVICE, AND COMPUTER PROGRAM PRODUCT FOR DETERMINING INACTIVE TIME OF DRUG INFUSION CALCULATORFebruary 2023July 2025Allow2900NoNo
18164669TECHNIQUES FOR DETERMINING MEDICATION CORRECTION FACTORS IN AUTOMATIC MEDICATION DELIVERY SYSTEMSFebruary 2023March 2026Allow3710NoNo
18163718SENSOR DATA CALIBRATION BASED ON WEIGHTED VALUESFebruary 2023January 2026Allow3610YesNo
18162033SYSTEM AND METHOD FOR ADJUSTING INSULIN DELIVERYJanuary 2023October 2025Allow3220NoNo
18161226INTEGRATED VASCULAR DELIVERY SYSTEMJanuary 2023April 2025Allow2610NoNo
18100696APPARATUSES AND METHODS FOR TREATING OPHTHALMIC DISEASES AND DISORDERSJanuary 2023August 2025Allow3110NoNo
18150134ALERT MANAGEMENT BASED ON SLEEPING STATUSJanuary 2023July 2025Allow3120YesNo
18148920Computerized system and method for the determination of a drug dosage, and computer programDecember 2022January 2026Allow3710NoNo
18067417PREDICTION BASED DELIVERING OR GUIDING OF THERAPY FOR DIABETESDecember 2022March 2025Allow2710NoNo
18066517METHOD FOR FABRICATING WEARABLE HYDROGEL GLUCOSE SENSORDecember 2022July 2023Allow700NoNo
18066790INJECTION MONITORING DEVICEDecember 2022March 2025Allow2710NoNo
18078346DEVICE AND METHOD FOR DELIVERING A MEDICAMENTDecember 2022January 2025Allow2600NoNo
18060273MEALTIME DELIVERY OF CORRECTION BOLUSESNovember 2022March 2026Allow3910YesNo
18060268REAL-TIME MEAL DETECTION BASED ON SENSOR GLUCOSE AND ESTIMATED PLASMA INSULIN LEVELSNovember 2022January 2026Allow3710YesNo
18072207LOW CONCENTRATION DELIVERY OF AN ERGOLINE DERIVATIVE FOR TREATMENT OF A HEADACHENovember 2022May 2025Allow2910NoNo
18059868CONTROLLING INSULIN DELIVERYNovember 2022July 2025Allow3210NoNo
17993393SYSTEMS AND METHODS FOR INFUSION PUMP FORMULARY VALIDATIONNovember 2022August 2025Allow3300NoNo
18058041SYSTEMS AND METHODS FOR DELIVERING MICRODOSES OF MEDICATIONNovember 2022February 2023Allow300NoNo
17987324AUTO-INJECTORS FOR ADMINISTRATION OF A MEDICAMENT WITHIN A PREFILLED SYRINGENovember 2022March 2026Allow4010YesNo
17984100PRE-CONNECTED ANALYTE SENSORSNovember 2022April 2025Abandon2910NoNo
17977908PRE-CONNECTED ANALYTE SENSORSOctober 2022November 2025Abandon3710NoNo
17972117IMPLANTABLE CELLULAR AND BIOTHERAPEUTIC AGENT DELIVERY CANISTEROctober 2022August 2023Allow1011NoNo
17964513SYSTEMS AND METHODS FOR DELAYED MEAL BOLUSES IN AUTOMATED INSULIN DELIVERYOctober 2022November 2025Allow3700NoNo
17996039MEDICATION DELIVERY SIMULATION SYSTEMOctober 2022November 2025Allow3710YesNo
17916176METHOD FOR PRODUCING A DRIP CHAMBER, DRIP CHAMBER, INFUSION SYSTEM OR TRANSFUSION SYSTEMSeptember 2022March 2026Allow4220NoNo
17936750OPTIMIZED BIO-SYNCHRONOUS BIOACTIVE AGENT DELIVERY SYSTEMSeptember 2022February 2026Allow4010YesNo
17956464EMBOLIC AGENT KITSeptember 2022July 2025Allow3400NoNo
17935483TECHNIQUES ENABLING ADAPTATION OF PARAMETERS IN AID SYSTEMS BY USER INPUTSeptember 2022April 2023Allow610YesNo
17933249SYSTEM AND METHOD FOR ADJUSTING INSULIN DELIVERYSeptember 2022February 2025Allow2910YesNo
17932496Using an Online Disturbance Rejection and Anticipation System to Reduce HyperglycemiaSeptember 2022October 2025Allow3710NoNo
17932241INTRAVENOUS INFUSION PUMP WITH CASSETTE INSERTION AND PUMP CONTROL USER INTERFACESeptember 2022October 2025Allow3710YesNo
17792337INJECTION SYSTEM, DATA CREATION METHOD, AND DATA CREATION PROGRAMSeptember 2022October 2025Allow3910YesNo
17905494DEVICE FOR CONTROLLING INJECTION OF MEDICINAL FLUIDSeptember 2022November 2025Allow3910NoNo
17896492SYSTEMS AND METHODS FOR MEDICAL DEVICE SETTINGS INITIALIZATION AND ADAPTATIONAugust 2022September 2025Allow3600NoNo
17892301ANTI-ARRHYTHMIC COMPOSITIONS AND METHODSAugust 2022July 2025Allow3511NoNo
17821150DYNAMIC FORECASTSAugust 2022December 2024Allow2800NoNo
17889611SYSTEM AND METHOD FOR PREDICTING BLOOD-GLUCOSE CONCENTRATIONAugust 2022March 2026Allow4310NoNo
17884508EXOSKELETON DEVICE WITH EXPANDABLE SECTION FOR SCORINGAugust 2022March 2025Allow3110YesNo
17818504USER PARAMETER DEPENDENT COST FUNCTION FOR PERSONALIZED REDUCTION OF HYPOGLYCEMIA AND/OR HYPERGLYCEMIA IN A CLOSED LOOP ARTIFICIAL PANCREAS SYSTEMAugust 2022June 2025Allow3410NoNo
17818136Systems and Methods for Monitoring and Controlling Fluid Infusion to a PatientAugust 2022October 2024Allow2600NoNo
17882469EMERGENCY MEDICAMENT DOSE CONTROLAugust 2022September 2025Allow3710NoNo
17878217INFUSION DEVICE SYSTEM AND APPARATUSAugust 2022May 2025Allow3311NoNo
17876862MEDICAMENT DELIVERY DEVICEJuly 2022December 2024Allow2800NoNo
17759512METHOD AND APPARATUS FOR DISPLAYING PROGRESS INFORMATIONJuly 2022June 2025Allow3500YesNo
17812817ADAPTATION OF MEDICAMENT DELIVERY IN RESPONSE TO USER STRESS LOADJuly 2022February 2026Allow4310NoNo
17812066METHOD FOR MODIFICATION OF INSULIN DELIVERY DURING PREGNANCY IN AUTOMATIC INSULIN DELIVERY SYSTEMSJuly 2022September 2025Allow3810NoNo
17810559SYSTEM FOR MONITORING AND DELIVERING MEDICATION TO A PATIENT AND METHOD OF USING THE SAME TO MINIMIZE THE RISKS ASSOCIATED WITH AUTOMATED THERAPYJuly 2022October 2025Allow3910NoNo
17851068Method and System of Remote Control and Remote Monitor in Treating Respiratory PatientsJune 2022October 2022Allow410NoNo
17848675ADJUSTMENT OF MEDICAMENT DELIVERY BY A MEDICAMENT DELIVERY DEVICE BASED ON MENSTRUAL CYCLE PHASEJune 2022September 2025Allow3910NoNo
17787593UNILATERALLY DRIVEN CLOSED-LOOP ARTIFICIAL PANCREAS AND DATA OBTAINING METHOD FOR PROGRAM MODULE THEREOFJune 2022September 2025Allow3910NoNo
17843631Feedback Mechanism for an Injection DeviceJune 2022March 2025Abandon3310NoNo
17842564Fluid Delivery and Measurement Systems and MethodsJune 2022May 2025Abandon3510NoNo
17841042LOW CONCENTRATION DELIVERY OF AN ERGOLINE DERIVATIVE FOR TREATMENT OF A HEADACHEJune 2022October 2022Allow410NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner MENDEZ, MANUEL A.

Strategic Value of Filing an Appeal

Total Appeal Filings
12
Allowed After Appeal Filing
5
(41.7%)
Not Allowed After Appeal Filing
7
(58.3%)
Filing Benefit Percentile
69.6%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 41.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner MENDEZ, MANUEL A - Prosecution Strategy Guide

Executive Summary

Examiner MENDEZ, MANUEL A works in Art Unit 3783 and has examined 664 patent applications in our dataset. With an allowance rate of 93.2%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 29 months.

Allowance Patterns

Examiner MENDEZ, MANUEL A's allowance rate of 93.2% places them in the 80% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by MENDEZ, MANUEL A receive 1.11 office actions before reaching final disposition. This places the examiner in the 12% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by MENDEZ, MANUEL A is 29 months. This places the examiner in the 67% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +6.7% benefit to allowance rate for applications examined by MENDEZ, MANUEL A. This interview benefit is in the 34% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 33.0% of applications are subsequently allowed. This success rate is in the 71% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 65.5% of cases where such amendments are filed. This entry rate is in the 89% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 77% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 63.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 22.0% are granted (fully or in part). This grant rate is in the 11% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 4.7% of allowed cases (in the 85% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 23.3% of allowed cases (in the 94% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.